Business Description
Uni-Bio Science Group Ltd
ISIN : KYG9198H1406
Total Employee Number:
543Compare
Compare
Traded in other countries / regions
00690.Hong KongUNBSF.USA IPO Date
2001-12-11Description
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.73 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 0.95 | |||||
Interest Coverage | 66.44 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.83 | |||||
Beneish M-Score | -2.31 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.4 | |||||
3-Year EBITDA Growth Rate | 28.1 | |||||
3-Year EPS without NRI Growth Rate | 31.7 | |||||
3-Year FCF Growth Rate | 26 | |||||
3-Year Book Growth Rate | 30.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.56 | |||||
9-Day RSI | 30.72 | |||||
14-Day RSI | 31.17 | |||||
3-1 Month Momentum % | -11.24 | |||||
6-1 Month Momentum % | -31.3 | |||||
12-1 Month Momentum % | -50.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.23 | |||||
Quick Ratio | 2.87 | |||||
Cash Ratio | 1.63 | |||||
Days Inventory | 109.41 | |||||
Days Sales Outstanding | 43.32 | |||||
Days Payable | 64.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.22 | |||||
Dividend Payout Ratio | 0.19 | |||||
Forward Dividend Yield % | 5.22 | |||||
5-Year Yield-on-Cost % | 5.22 | |||||
3-Year Average Share Buyback Ratio | 2.1 | |||||
Shareholder Yield % | 5.73 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 83.17 | |||||
Operating Margin % | 17.07 | |||||
Net Margin % | 15.92 | |||||
EBITDA Margin % | 17.58 | |||||
FCF Margin % | 15.15 | |||||
OCF Margin % | 15.15 | |||||
ROE % | 24.96 | |||||
ROA % | 16.93 | |||||
ROIC % | 26.2 | |||||
3-Year ROIIC % | 26.27 | |||||
ROC (Joel Greenblatt) % | 52.06 | |||||
ROCE % | 23.31 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.69 | |||||
PE Ratio without NRI | 3.69 | |||||
Price-to-Owner-Earnings | 5.9 | |||||
PS Ratio | 0.6 | |||||
PB Ratio | 0.84 | |||||
Price-to-Tangible-Book | 0.98 | |||||
Price-to-Free-Cash-Flow | 3.93 | |||||
Price-to-Operating-Cash-Flow | 3.93 | |||||
EV-to-EBIT | 2.79 | |||||
EV-to-EBITDA | 2.79 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-FCF | 3.23 | |||||
Price-to-GF-Value | 0.66 | |||||
Price-to-Projected-FCF | 0.74 | |||||
Price-to-Median-PS-Value | 0.19 | |||||
Price-to-Graham-Number | 0.39 | |||||
| Price-to-Net-Current-Asset-Value | 1.97 | |||||
Earnings Yield (Greenblatt) % | 35.84 | |||||
FCF Yield % | 25.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Uni-Bio Science Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 586.211 | ||
| EPS (TTM) (HK$) | 0.016 | ||
| Beta | 0.197 | ||
| 3-Year Sharpe Ratio | 0.38 | ||
| 3-Year Sortino Ratio | 0.84 | ||
| Volatility % | 28.79 | ||
| 14-Day RSI | 31.17 | ||
| 14-Day ATR (HK$) | 0.005511 | ||
| 20-Day SMA (HK$) | 0.07165 | ||
| 12-1 Month Momentum % | -50.31 | ||
| 52-Week Range (HK$) | 0.049 - 0.167 | ||
| Shares Outstanding (Mil) | 5,971.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Uni-Bio Science Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Uni-Bio Science Group Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.003130 Cash Dividend | 2026-05-28 | 0.09 (+5.88%) | ||
| HKD 0.002770 Cash Dividend | 2025-05-28 | 0.08 (+0.00%) | ||
| 0.1:1 Stock Split | 2009-08-31 | 0.65 (-4.41%) | ||
| 7:1 Stock Split | 2007-08-22 | 7.97 (-4.62%) |
Show
Entries
Uni-Bio Science Group Ltd Frequently Asked Questions
What is Uni-Bio Science Group Ltd(HKSE:00690)'s stock price today?
The current price of HKSE:00690 is HK$0.06. The 52 week high of HKSE:00690 is HK$0.17 and 52 week low is HK$0.05.
When is next earnings date of Uni-Bio Science Group Ltd(HKSE:00690)?
The next earnings date of Uni-Bio Science Group Ltd(HKSE:00690) is .
Does Uni-Bio Science Group Ltd(HKSE:00690) pay dividends? If so, how much?
The Dividend Yield %  of Uni-Bio Science Group Ltd(HKSE:00690) is 5.22% (As of Today), Highest Dividend Payout Ratio of Uni-Bio Science Group Ltd(HKSE:00690) was 0.19. The lowest was 0.19. And the median was 0.19. The  Forward Dividend Yield % of Uni-Bio Science Group Ltd(HKSE:00690) is 5.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Uni-Bio Science Group Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers